The American College of Cardiology (ACC) and the American Heart Association (AHA) separately announced publication of the 2025 m ...

Merit Medical Systems, Inc. recently announced the United States commercial release of the Prelude Wave hydrophilic sheath intro ...

BioLab Holdings, Inc., recently announced the initiation of the BIOCAMP study assessing the company’s human placental memb ...

Instylla, Inc. announced premarket approval (PMA) from the FDA for the company’s flagship Embrace hydrogel embolic system.

HistoSonics, the developer of the Edison histotripsy system and histotripsy therapy platform, announced a management-led majority ...

Royal Philips recently announced FDA 510(k) clearance of the latest version of the company’s UroNav system for image-guided ...

Instylla, Inc., a privately held clinical-stage company developing solutions for peripheral vascular embolization, announced ...

The Society of Interventional Oncology (SIO) recently announced the completion of enrollment for its clinical trial, ...

July 28, 2025—AngioDynamics, Inc. announced enrollment of the first patient in the AMBITION BTK study of the Auryon atherectomy system. According to the company, AMBITION BTK is a prospective, ...

July 22, 2025—InterVene, Inc., a developer of interventional devices for venous inflow and outflow obstructions, announced that the first-in-human (FIH) procedure with its Recana thrombectomy catheter ...